Browsing by Author Karteris, E

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 58 to 77 of 88 < previous   next >
Issue DateTitleAuthor(s)
12-Sep-2019Kinase inhibitors and ovarian cancerKatopodis, P; Chudasama, D; Wander, G; Sales, L; Kumar, J; Pandhal, M; Anikin, V; Chatterjee, J; Hall, M; Karteris, E
21-Jan-2020Lack of association between screencell-detected circulating tumour cells and long-term survival of patients undergoing surgery for non-small cell lung cancer: A pilot clinical studyBarr, J; Chudasama, D; Rice, A; Karteris, E; Anikin, V
7-Mar-2019Liquid biopsies in lung cancer: Four emerging technologies and potential clinical applicationsChudasama, D; Katopodis, P; Stone, N; Haskell, J; Sheridan, H; Gardner, B; Urnovitz, H; Schuetz, E; Beck, J; Hall, M; Barr, J; Sisu, C; Rice, A; Polychronis, A; Anikin, V; Karteris, E
17-Jul-2023Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology dataEastwood, M; Marc, ST; Gao, X; Sailem, H; Offman, J; Karteris, E; Fernandez, AM; Jonigk, D; Cookson, W; Moffatt, M; Popat, S; Minhas, F; Robertus, JL
23-Feb-2023MesoGraph: Automatic Profiling of Malignant Mesothelioma Subtypes from Histological ImagesEastwood, M; Sailem, H; Tudor, S; Gao, X; Offman, J; Karteris, E; Montero Fernandez, A; Jonigk, D; Cookson, W; Moffatt, M; Popat, S; Minhas, F; Lukas Robertus, J
9-Oct-2023MesoGraph: Automatic profiling of mesothelioma subtypes from histological imagesEastwood, M; Sailem, H; Marc, ST; Gao, X; Offman, J; Karteris, E; Fernandez, AM; Jonigk, D; Cookson, W; Moffatt, M; Popat, S; Minhas, F; Robertus, JL
8-Dec-2022A Meta-analysis of 2D vs. 3D Ovarian Cancer Cellular ModelsKerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C
2017Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cellsWagner, R; Stubiger, G; Veigel, D; Wuczkowski, M; Lanzerstorfer, P; Weghuber, J; Karteris, E; Nowikovsky, K; Wilfinger-Lutz, N; Singer, CF; Colomer, R; Benhamu, B; Lopez-Rodriguez, ML; Valent, P; Grunt, TW
15-Sep-2020Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Karteris, E; Kyrou, I
18-Jan-2021Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19Kyrou, I; Randeva, HS; Spandidos, DA; Karteris, E
28-Mar-2022NUCB2/Nesfatin-1 Reduces Obesogenic Diet Induced Inflammation in Mice Subcutaneous White Adipose TissueGharanei, S; Ramanjaneya, M; Patel, AH; Patel, V; Shabir, K; Auld, C; Karteris, E; Kyrou, I; Randeva, HS
30-Apr-2021On the role of artificial intelligence in medical imaging of COVID-19Born, J; Beymer, D; Rajan, D; Coy, A; Mukherjee, VV; Manica, M; Prasanna, P; Ballah, D; Guindy, M; Shaham, D; Shah, PL; Karteris, E; Robertus, JL; Gabrani, M; Rosen-Zvi, M
2015Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103Davies, J; Chen, J; Pink, R; Carter, D; Saunders, N; Sotiriadis, G; Bai, B; Pan, Y; Howlett, D; Payne, A; Randeva, H; Karteris, E
9-Jul-2021A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancerKerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E
26-May-2020Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19Katopodis, P; Anikin, V; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E
9-Jun-2017Perioperative detection of circulating tumour cells in patients with lung cancerChudasama, D; Burnside, N; Beeson, J; Karteris, E; Rice, A; Anikin, V
2012Placental DEPTOR as a stress sensor during pregnancyMparmpakas, D; Zachariades, E; Goumenou, A; Gidron, Y; Karteris, E
15-Jul-2020Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemicKyrou, I; Karteris, E; Robbins, T; Chatha, K; Drenos, F; Randeva, HS
15-Sep-2021Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of Brca2 StatusSaravi, S; Alizzi, Z; Tosi, S; Hall, M; Karteris, E
1-Mar-2016The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitroMankarious, A; Dave, F; Pados, G; Tsolakidis, D; Gidron, Y; Pang, Y; Thomas, P; Hall, M; Karteris, E